Epidemiological Aspects and World Distribution of HTLV-1 Infection.
about
Highlights on distinctive structural and functional properties of HTLV Tax proteinsHTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZHepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugsMolecular Mechanisms of HTLV-1 Cell-to-Cell TransmissionMother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child TransmissionSeroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in AfricaMolecular Studies of HTLV-1 Replication: An UpdateRoles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related DiseasesHTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular SignalingThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisModes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and PersistenceOrigin and diversity of human retrovirusesEvolution of foamy viruses: the most ancient of all retrovirusesPhysiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectivesOrigin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the AmericasAutoimmunity and infection in Sjögren's syndromeFamily Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic ReviewTumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell LeukemiaEpidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central ChinaCSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesisRNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.Inferences about the global scenario of human T-cell lymphotropic virus type 1 infection using data mining of viral sequences.Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex.HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.Human T-Cell Lymphotropic Virus Types 1 and 2 Seropositivity among Blood Donors at Mbarara Regional Blood Bank, South Western Uganda.Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection.Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian AmazonUndifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report.Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.Human T-lymphotropic viruses (HTLV) in England and Wales, 2004 to 2013: testing and diagnoses.Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and JapanHTLV-1-induced leukotriene B4 secretion by T cells promotes T cell recruitment and virus propagationPathogen-driven cancers and emerging immune therapeutic strategies.Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event.Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriersMolecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in SpainPrevalence of HTLV-1/2 in pregnant women living in the metropolitan area of Rio de Janeiro.IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
P2860
Q21131117-EA5D83E2-E746-4184-BD03-C5FA32463223Q26744330-82EC886C-DDAC-4343-AA44-E990747188BDQ26749788-8AC36CBB-F2D7-4861-895F-088A88040DBFQ26752562-43800D55-A45F-4323-8F20-FC2C84212471Q26768624-29F7ACD7-A4FD-497A-8F8E-6AA6D5F9DE49Q26772130-9BED0A00-4496-496D-8FEF-94FE8316416BQ26772930-2156D389-53D4-493E-9D3C-370495610225Q26774352-0A826B68-BBDF-4F18-914A-2C79998E76B4Q26777804-B14577C1-EB05-4A02-B1E0-1C3EB2B95D0FQ26800055-72DD93D8-E2F3-4CD5-8877-0164FBA3E2A9Q26801294-D9608CB7-E0D9-4851-A968-D39ABDC123A0Q26849291-58DDE63A-704B-48D4-805F-0C55609F9718Q26852372-971E3208-635B-4833-B064-0FA5A96E37B0Q26865238-AB4D8FFB-1439-4F1C-8077-E8D98830C461Q26996748-B842DB72-EEF3-421C-B8F9-014ECC53DFADQ27026174-6BF29EA7-DE16-4DF7-9FB5-A058924A851DQ28066384-530C13CE-C6F6-4B08-B513-CABBC71BDF8CQ28081287-9AC5460E-A2B2-4267-8144-69709946CB80Q28534288-4C50810F-EBCF-41F2-AC60-B9335D677167Q28534309-EADF3144-1623-46A8-91AA-3477BC5D1422Q30252424-01D61409-3C34-44F9-9465-DCC0DC370023Q30826952-FFD32538-D0D1-4766-88E9-9A6BC3B6944EQ31156885-24E2C592-5E24-4F7C-B32D-314AE26418D1Q33425096-3D94B505-4DD4-4464-9A06-98FF72E71BE3Q33458088-1AA56F06-EAB2-43F5-A23F-17CA2897992BQ33590318-49884C87-C0F4-4EF5-8B3B-6A29030A5965Q33717705-065DEB41-F3A8-4836-9A00-02EC8BC6C316Q33720524-00909D87-2E5A-4F35-B7F8-C0BAA1249E71Q33759081-1197CDD6-8044-4BBA-99DD-E71D6738770AQ33822913-E72D3121-119C-478A-9FCE-E20426FC248DQ33832838-E1FDF9FE-5F64-4A04-BF6D-1286E5303E34Q33849793-447C3B1B-C543-4976-9B7F-9E2156C476B6Q34054175-4C63C168-52F1-4AC6-B7CE-BC350AEB2DF9Q34059550-8AF04C7D-9867-497C-950B-BAF75451F8EEQ34070440-E90F9E4F-5864-4F03-95EB-553045958EE2Q34105919-18927501-65D5-4739-BE52-23F29A462398Q34116882-82995BB5-6854-4D9B-B8E0-36119AE8D873Q34133650-6D29FA5F-97A2-46BA-9EEA-AAD39320CF34Q34214760-C1B10D74-5B6F-4718-ADEE-AD891118ABC8Q34316662-AACE22FD-9D4B-45DD-A389-27B1CD3A019E
P2860
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@ast
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@en
type
label
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@ast
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@en
prefLabel
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@ast
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@en
P2860
P356
P1476
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
@en
P2093
Olivier Cassar
P2860
P356
10.3389/FMICB.2012.00388
P577
2012-11-15T00:00:00Z